Title
The potential of mitochondrial modulation by neuroglobin in treatment of neurological disorders
Date Issued
01 January 2021
Access level
open access
Resource Type
review
Author(s)
University of Limerick
Publisher(s)
Elsevier Inc.
Abstract
Neuroglobin is the third member of the globin family to be identified in 2000 in neurons of both human and mouse nervous systems. Neuroglobin is an oxygen-binding globin found in neurons within the central nervous system as well as in peripheral neurons, that produces a protective effect against hypoxic/ischemic damage induced by promoting oxygen availability within the mitochondria. Numerous investigations have demonstrated that impaired neuroglobin functioning is implicated in the pathogenesis of multiple neurodegenerative disorders. Several in vitro and animal studies have reported the potential of neuroglobin upregulation in improving the neuroprotection through modulation of mitochondrial functions, such as ATP production, clearing reactive oxygen species (ROS), promoting the dynamics of mitochondria, and controlling apoptosis. Neuroglobin acts as a stress-inducible globin, which has been associated hypoxic/ischemic insults where it acts to protect the heart and brain, providing a wide range of applicability in the treatment of human disorders. This review article discusses normal physiological functions of neuroglobin in mitochondria-associated pathways, as well as outlining how dysregulation of neuroglobin is associated with the pathogenesis of neurodegenerative disorders.
Start page
471
End page
477
Volume
162
Language
English
OCDE Knowledge area
Neurología clínica
Ciencias médicas, Ciencias de la salud
Scopus EID
2-s2.0-85096184583
PubMed ID
Source
Free Radical Biology and Medicine
ISSN of the container
08915849
Sources of information:
Directorio de Producción Científica
Scopus